1 What is… ?. 2 3 4 Disparities Among Women in Acute Cardiac Care Frances Canet, MD Cath Conference Thursday, May 26, 2011.

Slides:



Advertisements
Similar presentations
Unstable angina and NSTEMI
Advertisements

Preventing Strokes One at a Time Acute Interventions and Management 2009.
Trends in the Use of Evidence-Based Treatments for Coronary Artery Disease Among Women and the Elderly Findings From the Get With the Guidelines Quality-
British Cardiac Intervention Society Risk Assessment In Acute Coronary Syndromes Dr David Newby BHF Senior Lecturer in Cardiology Associate Director of.
A few basics of cardiac surgery…. Brett Sheridan, MD Assistant Professor Department of Surgery.
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery 2007 ACC/AHA and 2009 ESC GUIDELINES.
Women and Heart Disease: Triage Criteria Symptoms versus Reality.
Acute Coronary Syndrome. Acute Coronary Syndrome (ACS) Definition of ACS Signs and symptoms of ACS Gender and age related difference in ACS Pathophysiology.
Questions for Thelma McKenzie: 1.Should it be assumed that the learners know all of the terminology, or should a glossary be included for review? 2.What.
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
December Cardiac Rehabilitation Are you or someone you know missing the benefits of Cardiac Rehabilitation?
SIGN CHD In Scotland in the year ending 31 March 2006 over 10,300 patients died from CHD and 5,800 from cerebrovascular disease, with.
CARDIOVASCULAR DISEASE National Healthcare Quality and Disparities Report Chartbook on Effective Treatment.
Coronary Artery Disease Angina Pectoris Unstable Angina Variant Angina Joseph D. Lynch, MD.
One stage coronary and peripheral intervention Pawel Buszman, MD, American Heart of Poland, Ustron Silesian Medical School, Katowice.
Cardiovascular Disease in Women Module V: Prognosis and Treatment Outcomes.
1 1 The Use of Percutaneous Coronary Intervention in Patients with Class I Indications for Coronary Artery Bypass Graft Surgery: Data from the National.
10 Points to Remember on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsTreatment of Blood Cholesterol to Reduce.
1 EFFECT STUDY 2 EFFECT STUDY  Set national cardiac care benchmarks for hospitals to work towards 
Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Trial MEGA Trial Presented at The American Heart Association.
CPORT- E Trial Randomized trial comparing outcomes of non-primary PCI at hospitals with and without on-site cardiac surgery.
Incremental Decrease in Clinical Endpoints Through Aggressive Lipid Lowering (IDEAL) Trial IDEAL Trial Presented at The American Heart Association Scientific.
Silent Ischemia STABLE CAD
Critical Appraisal Did the study address a clearly focused question? Did the study address a clearly focused question? Was the assignment of patients.
Aim To determine the effects of a Coversyl- based blood pressure lowering regimen on the risk of recurrent stroke among patients with a history of stroke.
Which Early ST-Elevation Myocardial Infarction Therapy (WEST) Trial Paul W. Armstrong, WEST Steering Committee Published in The European Heart Journal.
Community Outreach to Reduce Disparities in Cardiovascular & Diabetes Morbidity & Mortality in the South Bronx Michael Alderman, MD Michelle Johnson, MD,
Acute Coronary Syndromes. Learning outcomes To understand the clinical spectrum of coronary disease To recognise different presentations of the disease.
The Impact of For-Profit Hospital Status on the Care and Outcomes of Patients with NSTEMI: Results From CRUSADE Bimal R. Shah, MD, Seth W. Glickman, MD,
Clinical Trial Results. org Characteristics, Management, and Outcomes of 5,557 Patients Age ≥90 Years With Acute Coronary Syndromes: Results From the CRUSADE.
Coronary Heart Disease (CHD) László Tornóci Inst. Pathophysiology Semmelweis University.
4S: Scandinavian Simvastatin Survival Study
MICHELANGELO: OASIS 5 Women’s Substudy Dr. Eva Swahn Department of Cardiology, Heart Centre, University Hospital, Linköping Sweden Disclosure Funded by.
FRagmin® and Fast Revascularization during InStablity in Coronary artery disease FRISC II.
Ischemia Management with Accupril Post Bypass Graft via Inhibition of Angiotensin Converting Enzyme IMAGINEIMAGINE Presented at The European Society of.
Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Long-term Risk of Mortality and End-Stage Renal Disease.
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for.
Date of download: 5/28/2016 From: Optimal Timing of Coronary Invasive Strategy in Non–ST-Segment Elevation Acute Coronary Syndromes: A Systematic Review.
Women reaching equality in health, despite the differences Nowadays women remain the largest CAD population subgroup being under-diagnosed and under-treated.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early and long-term clinical outcomes associated.
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Interactions Between COPD and Outcomes After Percutaneous Coronary Intervention Tomas Konecny, Krishen Somers, Marek Orban, Yuki Koshino, Ryan J. Lennon,
Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: Readmissions After Carotid Artery Revascularization.
Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Making Sense of Statistics in Clinical Trial Reports:
From: Bivalirudin Versus Heparin With or Without Glycoprotein IIb/IIIa Inhibitors in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention:
Choosing Wisely: Cardiology Jeffrey Ziffra D.O. Mercy Medical Center – North Iowa 10/14/2016.
Atherosclerotic Cardiovascular Heart Disease in Women
Copyright © 2008 American Medical Association. All rights reserved.
Gender differences in the management of acute coronary syndrome patients: One year results from HPIAR (HP-India ACS Registry) Kunal Mahajan*, Negi PC,
Management of ST-Elevation Myocardial Infarction
HOPE: Heart Outcomes Prevention Evaluation study
Women, Bleeding, and Coronary Intervention
Chapter 8: Cardiovascular Disease in Patients with ESRD
Volume 1: Chronic Kidney Disease
Gender Disparity in Treatment of Coronary Artery Disease?
 Gender based differences in the presentation, treatment and outcome of Acute Coronary Syndrome patients : insights from the Himachal Pradesh ACS-registry.
Ischaemic Heart Disease Acute Coronary Syndrome
Copyright © 2009 American Medical Association. All rights reserved.
CHD-related catheterization
Nursing Management: Patients With Coronary Vascular Disorders
Chapter 28 Management of Patients With Coronary Vascular Disorders
European Heart Association Journal 2007 April
Sex Differences in Clinical Profiles and Quality of Care Among Patients With ST‐Segment Elevation Myocardial Infarction From 2001 to 2011: Insights From.
ARISE Trial Aggressive Reduction of Inflammation Stops Events
Urban–Rural Comparisons in Hospital Admission, Treatments, and Outcomes for ST-Segment–Elevation Myocardial Infarction in China From 2001 to 2011 A Retrospective.
Atlantic Cardiovascular Patient Outcomes Research Team
The following slides highlight a report on a presentation at the American College of Cardiology 2004, Scientific Sessions, in New Orleans, Louisiana on.
Lee A. Fleisher et al. JACC 2014;64:e77-e137
Cardiovascular Epidemiology and Epidemiological Modelling
Presentation transcript:

1 What is… ?

2

3

4 Disparities Among Women in Acute Cardiac Care Frances Canet, MD Cath Conference Thursday, May 26, 2011

5 Gender Disparities Across the Spectrum of Acute Cardiac Care Epidemiology Diagnosis Evaluation Treatment Medications Interventions Outpatient Follow-up Outcomes

6Epidemiology L eading Causes of Death for American Women (2005)

7 Heart Disease Death Rates Adults Ages 35 Years and Older by County

8 Among women ages 18 and older: 17.3 % are smokers 51.6% are overweight (BMI greater than 25) 27% have hypertension 35% have high cholesterol 53% do not meet physical activity recommendations.

9 Age Difference - Heart disease mortality increases for both women and men with age. - For men, mortality is increased at all ages. - In women, the heart disease manifestation is delayed 10 years.

10 Symptomatic Presentation of MI For both genders, the predominant symptoms is chest pain. Women are more likely to have atypical symptoms -Abdominal pain -Neck and shoulder pain -Painless dyspnea and extreme fatigue in older women and in women with diabetes

11 Diagnosis The pretest probability of coronary heart disease is lower in women with chest pain presenting for diagnostic evaluation compared to men.

12 Evaluation Gender Disparities in the Diagnosis and Treatment of Non-ST Segment Elevation Acute Coronary Syndromes 2005 –CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines)

13 Study Highlights - Involved about 35,000 patients of which 41% were women. - Women were older (73 vs. 65) and more often had diabetes and hypertension. - Women were less likely to receive acute heparin, angiotensin converting enzyme inhibitors (ACEi), and glycoprotein IIb/IIIa inhibitors. - Women were also less likely to receive aspirin, ACEi and statins at discharge. - Cardiac catheterization and revascularization was higher in men.

14 Study Highlights (continued) - Among patient with significant CAD, percutaneous revascularization was performed in a similar proportion of women and men. - Higher in hospital death for women (5.6% vs. 4.3%) - Higher risk for re-infarction (4.0% vs. 3.5%) - Higher risk for heart failure (12.1% vs. 8.8%) - Higher risk of stroke (1.1% vs. 0.8%) - Higher risk of red blood cell transfusion (17.2% vs. 13.2%)

15 Treatment Women were: - less likely to have an ECG performed with 10 minutes of hospital presentation (25.2% vs. 29.3% for men) -less likely to be cared for by a cardiologist (53.4% vs. 63.4% for men)

16 Interventions Men were: -more likely to undergo diagnostic catheterization -more likely to have revascularization procedures Women were: -more likely to undergo stress testing -less likely to receive coronary thrombolysis, and more likely to have major bleeding if they did

17 Race and Gender Disparities in Rates of Cardiac Revascularization -Do disparities reflect appropriate use of procedures or problems in quality of care? -Randomized 5026 Medicare beneficiaries aged Compared underuse or the failure to receive a clinically indicated revascularization procedure vs. receipt of a revascularization that was not clinically indicated.

18 Race and Gender Disparities in Rates of Cardiac Revascularization Results: -Revascularization was more clinically indicated among whites than black and among men than women. -Failure to receive vascularization was more common among blacks than whites (40% vs %), but similar among men and women (25% vs %)

19 Race and Gender Disparities in Rates of Cardiac Revascularization Results: -Among patients who received inappropriate revascularization, use was greater for whites than blacks using RAND criteria (10.5% vs.5.8%) -Greater for men than for women (14.2% vs. 5.3% by RAND criteria)

20 Disparities in the Outcome of Cardiac Interventions -204 women compared to 577 men who had undergone direct angiography/primary PTCA for acute STEMI -PTCA was equally successful (95% in women, 94% in men) -No difference in 30 day mortality -Higher post-discharge mortality after 3 years, significant after 4 years.

21 Reasons for improvement in peri- procedural complication rates and long-term outcome after PCI in women. -Improvement of interventional techniques -Increase in number of implanted stents -Improvement of antithrombotic medications -Statins -Intensive control of cardiovascular risk factors (diabetes)

22 Coronary Artery Bypass Graft Surgery -Women are usually older with more frequent comorbidity (DM, HTN). -Perioperative mortality rate of 4.5% for women compared with 1.9% for men. -Post-operatively women had a comparable 15-year survival to men.

23 Do gender disparities exist if access to medical care is controlled? -”Sex and Racial/Ethnic Disparities in Outcomes After Acute Myocardial Infarction” -Relative to white men, black men: Hazard ratio for increase risk of acute MI recurrence was Black women: Asian women :1.37

24 More gender disparities Women were less likely then men to receive Aspirin and Nitroglycerin in the out-of- hospital management of chest pain.

25 Why the disparity? Driven by patient preferences. The manner in which chest pain is recognized or diagnosed by out-of-hospital personnel. The gender of the provider, influences the delivery of cardiac care. Poor adherence to out-of-hospital chest pain protocols.

26 Disparities in Outpatient Care -Women were less likely than men to have low-density lipoprotein cholesterol controlled at <100mg/dL in those who have diabetes. -Among participants with diabetes, 44.3% of men and 38.5% of women met LDL control measures. -In patients with a history of cardiovascular disease, 55.6% of men and 46.6% of women met LDL control measures. -Women achieved higher performance than men in controlling blood pressure, 70.8% for women an 68.9% for men.

27 Disparities in Cardiovascular Disease Extend Into: Congestive heart failure Advanced heart failure therapies Arrhythmia Management and EP devices Cerebrovascular accidents

28 Summary -Cardiovascular disease is the number one cause of death among women, but awareness in the public is still growing. -Awareness for heart disease in women has become a topic of interest because of the vast disparities compared to men : presentation, diagnosis, treatment, outcome.

29 Conclusions -Despite protocols for management and treatment of heart disease, the gender disparity exists, except in coronary revascularization. -Data collection has been ongoing and yet mechanisms of disparities have yet to be delineated.

30 Conclusions -One would expect that with increased awareness of women’s heart disease and its risk factors among the general public coupled with care provider awareness about the disparities between men and women, the disparity gap will close. -Perhaps, the risk factors for cardiovascular disease need their own campaigns individually.

31 The End